Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.
2.
3.
4.

Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.

Amsterdam JD, Luo L, Shults J.

Br J Psychiatry. 2013 Apr;202(4):301-6. doi: 10.1192/bjp.bp.111.104711.

5.

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

Amsterdam JD, Garcia-EspaƱa F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.

J Clin Psychopharmacol. 1998 Dec;18(6):435-40.

PMID:
9864074
6.

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.

PMID:
18344727
7.

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

Amsterdam JD, Wang CH, Shwarz M, Shults J.

J Affect Disord. 2009 Jan;112(1-3):219-30. doi: 10.1016/j.jad.2008.03.029.

PMID:
18486235
8.
9.

Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.

Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.

Br J Psychiatry. 2016 Apr;208(4):359-65. doi: 10.1192/bjp.bp.115.169375.

PMID:
26892848
10.

Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2010 Jun;30(3):306-11. doi: 10.1097/JCP.0b013e3181da5300.

11.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
12.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
13.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
14.

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M; EMBOLDEN I (Trial 001) Investigators..

J Clin Psychiatry. 2010 Feb;71(2):150-62. doi: 10.4088/JCP.08m04995gre.

PMID:
20122369
15.

Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.

Amsterdam JD, Shults J, Brunswick DJ, Hundert M.

Bipolar Disord. 2004 Feb;6(1):75-81.

PMID:
14996144
16.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group..

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
17.
18.

Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.

Gao K, Kemp DE, Ganocy SJ, Muzina DJ, Xia G, Findling RL, Calabrese JR.

Bipolar Disord. 2008 Dec;10(8):907-15. doi: 10.1111/j.1399-5618.2008.00637.x.

PMID:
19594506
19.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, Martin-Santos R, Santiso A, Noguera R, Casais L, Perez-Camo V, Arias M, Judge R; Fluoxetine Long-Term Study Group..

J Clin Psychopharmacol. 2001 Aug;21(4):417-24.

PMID:
11476126
20.

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.

Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL.

Am J Psychiatry. 2005 Nov;162(11):2152-61.

PMID:
16263857

Supplemental Content

Support Center